4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-04-027264
Chief Scientific Officer bought 2,000 shares at an average $7.46 ($14,912)
From the SEC's structured data for this filing
Trades in this filing
CHAPLIN DAVID · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2004-05-21 | Purchase : show line 1 in the form | +200 | $7.47 | $1,494 | 200 | I |
| 2004-05-21 | Purchase : show line 2 in the form | +1,500 | $7.46 | $11,190 | 1,700 | I |
| 2004-05-21 | Purchase : show line 3 in the form | +200 | $7.45 | $1,490 | 1,900 | I |
| 2004-05-21 | Purchase : show line 4 in the form | +100 | $7.38 | $738 | 2,000 | I |
| Open-market purchases · 2,000 sh · avg $7.46 · $14,912 | ||||||
Loading xslF345X02/rrd43334.xml…